Dental Implants Market Size, Share & Trends Analysis | China | 2025-2031 | Includes: Dental Implants, Dental Final Abutments, and 3 more

The China dental implant and final abutment market was valued at nearly 604 million dollars in 2024. The market is forecast to grow to more than 1.3 billion dollars by 2031.

This report suite covers dental implants, final abutments, treatment planning software, and surgical guides.

Quantitative coverage includes unit sales, average selling prices, market size, growth rates, and company shares.

Qualitative coverage includes market drivers and limiters, recent mergers and acquisitions, company profiles, product portfolios, and competitive positioning across dental chains, specialist hospitals, and independent clinics.

A major policy force in China is volume-based procurement (VBP). VBP seeks to lower out-of-pocket costs by consolidating demand into tenders that reward lower unit prices.

The short-term effect is ASP compression on implant fixtures and, to a lesser extent, on abutments tied to the winning ecosystems.

The medium-term view is more balanced. As tenders expand patient access and help clinics serve more cases, procedure volumes rise, which can offset price declines at the total market level.

Vendors that align portfolios, education, and service with VBP outcomes are best positioned to defend share while participating in higher volumes.

Market Overview

China's implant market brings together three forces. First is patient demand driven by aesthetics, function, and a large base of partially edentulous adults. Second is care delivery scale, with fast-growing dental service organizations and specialist dental hospitals expanding capacity and adding implant chairs. Third is policy and pricing, centered on VBP and on the goal of lowering the total cost of care without reducing quality.

On the clinical side, the core platform is a titanium fixture placed in bone and a final abutment that connects the fixture to the crown or prosthesis. Around this platform, adoption of CBCT imaging, computer-guided surgery, and CAD or CAM abutments is steady in leading urban centers and academic hubs. These tools improve accuracy, shorten chair time, and reduce remakes. They also require investment in scanners, software, and staff skills, which can slow adoption in smaller clinics that operate on tight budgets.

The structure of the buyer base matters. Private dental chains such as Arrail Dental Group, Bybo Dental Group, and Jiamei Dental Group are expanding their networks. Chains can standardize systems, negotiate better pricing, and run education programs across locations. Independent clinics focus on reliability, availability of parts, and support from local distributors. Specialist dental hospitals handle complex cases and train residents on advanced workflows that include guided surgery and custom abutments.

Market Drivers

Improved supporting technology. The rise of CBCT scanners and planning software supports accurate 3D models, nerve mapping, sinus assessment, and guided osteotomy. Surgical guides built from these plans translate virtual positions into precise placement. These steps lower variability and reduce adjustment time during restoration. China will see continued adoption, although capital costs can delay purchases at general practices.

Growth of dental service organizations. The number of dental care organizations is growing to meet patient demand. Chains and specialist hospitals expand the number of patients per day and the range of procedures they can perform. Consolidation allows better inventory control, training, and protocol standardization, which supports higher case throughput and faster adoption of digital tools.

Demand for improved aesthetics. Implants are widely regarded as the best single-tooth replacement for natural look and function. Single-tooth cases are growing quickly as patients seek fixed solutions that preserve adjacent enamel. This shift increases implant penetration relative to conventional bridges.

Training and clinician capability. Growth in implant education through vendor programs, academic courses, and chain-led workshops improves clinician confidence. As more general practitioners gain experience, clinics can internalize straightforward cases and refer only the most complex work to specialists, which increases total implant volumes.

Market Limiters

Volume-based procurement and price pressure. VBP tenders place continued downward pressure on ASPs. Winning bids can secure high unit share within a province or nationally, which motivates lower prices. Over time, volume gains can offset value losses at the market level, but individual vendors face margin pressure and must adapt portfolios and service models to remain competitive.

Improvements in dental health. Better oral health reduces the pool of severe restorative cases. This tempers growth from aging demographics and can lower the number of multi-unit and full arch treatments that would otherwise support higher value per patient.

Costs and limited public coverage. There is no public insurance coverage for major dental procedures like implants. Out-of-pocket costs for an implant case in China can be well over 3,000 dollars including services. This limits adoption for many households and concentrates demand in middle and upper income urban segments unless VBP and chain pricing lower total costs.

Regulatory barriers. China's medical device regulation requires local approvals that can include in-country clinical data. Foreign manufacturers may face longer registration timelines. This can delay entry for restorative systems and reduce the short-term availability of new implant and abutment designs.

Market Coverage and Data Scope

Quantitative coverage. Market size, market shares, market forecasts, growth rates, units sold, and average selling prices.

Qualitative coverage. Growth drivers and limiters, competitive analysis and SWOT for top competitors, mergers and acquisitions, company profiles and product portfolios, technology and workflow trends, and the policy environment that shapes pricing and access.

Time frame. Historical data 2021 to 2024, forecasts 2025 to 2031, base year 2024.

Data sources. Primary interviews with industry leaders, government and regulatory data, hospital and chain inputs, import and export data, and the iData Research internal database.

Method note. Revenues are modeled as units multiplied by ASP, validated with adoption rates by setting and procedure mix across single-tooth, bridge, and denture securement applications.

Markets Covered and Segmentation

Dental Implants Market

Type. Premium, value, discount.

Shape. Parallel wall, tapered.

Material. Titanium, ceramic or zirconia.

Procedure type. One-stage, two-stage, immediate loading.

Connection type. Internal connection, external connection, one-piece.

Application. Single-tooth application, multi-tooth bridge partial arch securement, multi-tooth bridge full arch securement, denture securement.

Final Abutment Market

Fabrication. Stock, custom cast, CAD or CAM.

Material. Titanium, ceramic or zirconia, gold.

Type. Cement-retained, screw-retained, denture retaining.

Instrument Kit Market

Treatment Planning Software Market

Surgical Guide Market

Competitive Analysis

Straumann Group was the leading competitor in 2024. The brand has strong recognition with a record of high performance in premium implants and a broad implant-associated portfolio. The Neodent value brand has outpaced the market in the value tier, which strengthens overall share by capturing a larger range of clinical budgets. Ongoing mergers and acquisitions enhance portfolio reach across indications and materials and help Straumann defend leadership in an environment shaped by VBP and expanding chains.

Osstem Implant ranked second in China in 2024. The company has achieved strong recognition through education programs with the AIC network and a portfolio that includes the ET, MS, and SS implant systems. Osstem complements its implant and abutment lines with regenerative products, guided surgery systems, and selected operatory equipment such as dental chairs. This breadth helps clinics source from a single vendor and align training with product use.

Envista held the third largest share through Nobel Biocare. NobelActive and NobelReplace are supported by a robust prosthetic ecosystem, including the NobelProcera ASC abutment and the Omnigrip tool. Envista supplies both stock abutments and CAD or CAM abutments. Persistent price pressure shapes competitive tactics, yet the brand remains a preferred choice where clinics prioritize long-term evidence, service, and a clear digital workflow. Expansion into regenerative materials is expected to complement the implant portfolio.

Other participants compete at regional and local levels with focus on logistics, distributor relationships, and tailored support for independent clinics. Success factors across competitors include training capacity, reliable supply, broad prosthetic catalogs, and the ability to support both premium and value price points under VBP rules.

Technology and Practice Trends

CBCT and guided surgery. CBCT planning and surgical guides improve placement accuracy and reduce the need for restorative corrections. Adoption is highest in chains and in specialist hospitals. Smaller clinics often work with external labs that provide design and guide fabrication to avoid large capital purchases.

Internal connections and tapered designs. Internal connections offer prosthetic stability and torque control. Tapered implants support primary stability in a wide range of bone qualities and fit immediate or early loading protocols when clinical criteria are met.

Material use. Titanium remains the fixture standard for strength and osseointegration. Zirconia implants and zirconia abutments serve anterior esthetics and metal-free preferences. Hybrid abutment designs pair zirconia with titanium bases when strength and esthetics both matter.

Stock versus CAD or CAM abutments. Stock titanium abutments lead in volume due to cost and availability. CAD or CAM abutments gain share as chains and labs scale scanning and milling. Custom contours improve soft tissue outcomes and allow precise alignment of screw access for screw-retained restorations. Custom cast abutments remain useful for legacy connections and unusual angulations.

Clinic to lab collaboration. Outcome quality depends on tight coordination with labs for scan body use, emergence profile design, and occlusal planning. Chains standardize these steps and use internal or preferred labs that understand implant libraries and abutment options.

Geography

This edition covers China.

Why This Report

Where is the largest and fastest growing opportunity in China's implant and final abutment market, and how will VBP reshape price corridors and vendor strategies through 2031.

How will digitization change everyday workflows, including the pull-through for CBCT, planning software, surgical guides, scan bodies, and CAD or CAM abutments as chains and labs scale digital capacity.

Which abutment formats will gain share, and how should clinics balance stock, custom cast, and CAD or CAM to manage soft tissue, occlusion, and screw access while controlling cost.

How will dental service organizations influence procurement, training, and brand standardization, and what does this mean for premium versus value systems.

What is the practical impact of VBP on clinic economics, including case volumes, chair time, and remakes, and how can vendors design bundles and education that offset margin pressure.

What is the right mix of screw-retained and cement-retained designs by indication and setting, and how do protocols for cement control and retrievability affect long term maintenance.

Where are regulatory steps most likely to delay launches, and how should foreign manufacturers stage submissions, clinical evidence, and local partnerships to reduce time to market.

What risks could slow growth, including more aggressive ASP compression, slower digital adoption at smaller clinics, and limits on patient ability to pay in regions without strong chain penetration.

The China Dental Implant and Final Abutment Market report from iData Research answers these questions with price-tier models, company share analysis, and a clear view of digital and surgical workflows. Use it to size demand by category, set pricing strategies for VBP environments, plan product roadmaps, and design training and support programs that improve outcomes while controlling cost.